Our results are in line with previous evidence of elevated expression of S100A12 in coronary arteries from diabetic patients (compared to non-diabetic) [31], and that elevated plasma S100A12 has been associated with prevalence of cardiovascular disease [43] and PAD [32] in cross-sectional studies. The gene discussed is S100A12; the disease is peripheral arterial disease.